XRAY Relative Valuation
XRAY's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, XRAY is overvalued; if below, it's undervalued.
Historical Valuation
DENTSPLY SIRONA Inc (XRAY) is now in the Undervalued zone, suggesting that its current forward PE ratio of 8.72 is considered Undervalued compared with the five-year average of 17.29. The fair price of DENTSPLY SIRONA Inc (XRAY) is between 25.00 to 39.01 according to relative valuation methord. Compared to the current price of 16.20 USD , DENTSPLY SIRONA Inc is Undervalued By 35.2%.
Relative Value
Fair Zone
25.00-39.01
Current Price：16.20
35.2%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.65
P/B
Median3y
1.85
Median5y
2.06
8.37
FCF Yield
Median3y
5.76
Median5y
5.45
Competitors Valuation Multiple
The average P/S ratio for XRAY's competitors is 3.13, providing a benchmark for relative valuation. DENTSPLY SIRONA Inc Corp (XRAY) exhibits a P/S ratio of 0.90, which is -71.11% above the industry average. Given its robust revenue growth of -7.76%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is DENTSPLY SIRONA Inc (XRAY) currently overvalued or undervalued?
What is DENTSPLY SIRONA Inc (XRAY) fair value?
How does XRAY's valuation metrics compare to the industry average?
What is the current P/B ratio for DENTSPLY SIRONA Inc (XRAY) as of Jul 08 2025?
What is the current FCF Yield for DENTSPLY SIRONA Inc (XRAY) as of Jul 08 2025?
What is the current Forward P/E ratio for DENTSPLY SIRONA Inc (XRAY) as of Jul 08 2025?